<DOC>
	<DOCNO>NCT01264380</DOCNO>
	<brief_summary>This randomize , open-label , two period crossover study evaluate effect food pharmacokinetics single dose RO5185426 efficacy safety continuous administration patient BRAF V600E mutation-positive metastatic melanoma . Patients randomize receive crossover design single oral dos RO5185426 without food , 10-day washout period dos . Following crossover period , patient receive RO5185426 orally twice daily continuous basis disease progression unacceptable toxicity occur .</brief_summary>
	<brief_title>A Study Effect Food Pharmacokinetics Single Dose RO5185426 And Safety And Efficacy Continuous Administration Patients With BRAF V600E Mutation-Positive Metastatic Melanoma</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Adult patient , &gt; /= 18 year age Histologically confirm metastatic melanoma ( Stage IV , American Joint Committee Cancer ) Positive BRAF V600E mutation result determine Cobas 4800 BRAF V600 Mutation Test Previously treat patient must fail least one prior treatment regimen ; patient receive prior systemic treatment metastatic melanoma , time elapse previous therapy must &gt; /= 28 day ; patient must recover fully toxicity prior therapy Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Evaluable disease ( measurable disease progression accord RECIST criterion ) Adequate hematological , renal liver function Active CNS lesion History know spinal cord compression carcinomatous meningitis Anticipated ongoing administration anticancer therapy administer study Previous malignancy within past 5 year except basal squamous cell carcinoma skin , melanoma insitu carcinoma insitu cervix Previous treatment BRAF inhibitor ( sorafenib allow ) MEK inhibitor Refractory nausea vomiting , malabsorption , external biliary shunt , history type gastrointestinal surgery would preclude adequate absorption study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>